Chung Yoona, Cho In, Choi Yun Suk, Kim Yoo Min, Lee Yoontaek, Park Shin-Hoo, Jung Mi Ran, Kwon In Gyu, Kim Jongmin, Lee Sang Eok, Kim Jihun, Kong Seong-Ho, Seo Kyung Won, Choi Sung Il, Kim Jong-Han, Ha Tae Kyung, Kim Jin-Jo, Park Young Suk, Yoo Moon-Won, Kim Dong Jin, Park Ji Yeon, Yoo Han Mo, Lee Hyuk-Joon, Kim Sang Hyun, Lee Han Hong, Park Do Joong, Park Sungsoo, Han Sang-Moon, Kim Yong Jin, Park Joong-Min, Ryu Seung-Wan, Lee Sang Kuon, Park Jee Yoon, Kim Jong Won
Metabolic and Bariatric Surgery Center, Department of Surgery, H+ Yangji Hospital, Seoul, Korea.
Department of Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
J Metab Bariatr Surg. 2025 Apr;14(1):1-23. doi: 10.17476/jmbs.2025.14.1.1. Epub 2025 Apr 25.
Obesity has emerged as a major global health issue. The ratio of male to female patients undergoing metabolic bariatric surgery (MBS) is 1:3.5. Although not as dramatic compared to the global trend, the rate of obesity in women of reproductive age in Korea has been steadily increasing over the past several decades. The impact of obesity on reproductive health and perinatal outcomes should be carefully considered when consulting female candidates of reproductive age for MBS. Obesity adversely affects reproductive health by causing menstrual irregularities, anovulation, subfertility, and increased miscarriage risk, as well as impairing the success of assisted reproductive technologies. Maternal obesity also heightens the risk of adverse perinatal outcomes, including childhood obesity and metabolic disorders. MBS has been shown to improve fertility outcomes and reduce obesity-related pregnancy complications, although concerns remain regarding potential risks such as small-for-gestational-age infants due to rapid weight loss and nutritional deficiencies. Despite these implications, current MBS guidelines rarely address the unique needs of reproductive-age women. In response, the Korean Society for Metabolic and Bariatric Surgery convened a task force to develop evidence-based recommendations tailored to this population. This position statement aims to guide the management of obesity in women of reproductive age to optimize reproductive and perinatal outcomes.
肥胖已成为一个主要的全球健康问题。接受代谢性减肥手术(MBS)的男性与女性患者比例为1:3.5。尽管与全球趋势相比没有那么显著,但在过去几十年里,韩国育龄女性的肥胖率一直在稳步上升。在为育龄期女性MBS候选者提供咨询时,应仔细考虑肥胖对生殖健康和围产期结局的影响。肥胖会导致月经不调、无排卵、生育力低下、流产风险增加,还会影响辅助生殖技术的成功率,从而对生殖健康产生不利影响。母亲肥胖还会增加不良围产期结局的风险,包括儿童肥胖和代谢紊乱。尽管人们仍然担心诸如因快速体重减轻和营养缺乏导致的小于胎龄儿等潜在风险,但MBS已被证明可以改善生育结局并减少与肥胖相关的妊娠并发症。尽管有这些影响,但目前的MBS指南很少涉及育龄期女性的独特需求。作为回应,韩国代谢与减肥外科学会召集了一个特别工作组,以制定针对这一人群的循证建议。本立场声明旨在指导育龄期女性肥胖的管理,以优化生殖和围产期结局。